HER2 gene analyses are particularly suited to laser-microdissected cells because i) the level of gene amplification is correlated to protein overexpression, and ii) trastuzumab targets HER2 overexpressing tumor cells even in micro-invasive and micro-metastatic breast cancers. This evidence concerns the gene ERBB2 and breast cancer.